Role of nitric oxide in acetaminophen‐induced hepatotoxicity in the rat

Acetaminophen is a mild analgesic and antipyretic agent known to cause centrilobular hepatic necrosis at toxic doses. Although this may be due to a direct interaction of reactive acetaminophen metabolites with hepatocyte proteins, recent studies have suggested that cytotoxic mediators produced by parenchymal and nonparenchymal cells also contribute to the pathophysiological process. Nitric oxide is a highly reactive oxidant produced in the liver in response to inflammatory mediators. In the present studies we evaluated the role of nitric oxide in the pathophysiology of acetaminophen‐induced liver injury. Treatment of male Long Evans Hooded rats with acetaminophen (1 g/kg) resulted in damage to centrilobular regions of the liver and increases in serum transaminase levels, which were evident within 6 hours of treatment of the animals and reached a maximum at 24 hours. This was correlated with expression of inducible nitric oxide synthase (iNOS) protein in these regions. Hepatocytes isolated from both control and acetaminophen‐treated rats were found to readily synthesize nitric oxide in response to inflammatory stimuli. Cells isolated from acetaminophen‐treated rats produced more nitric oxide than cells from control animals. Production of nitric oxide by cells from both control and acetaminophen‐treated rats was blocked by aminoguanidine, a relatively specific inhibitor of iNOS. Arginine uptake and metabolism studies revealed that the inhibitory effects of aminoguanidine were due predominantly to inhibition of iNOS enzyme activity. Pretreatment of rats with aminoguanidine was found to prevent acetaminophen‐induced hepatic necrosis and increases in serum transaminase levels. This was associated with reduced nitric oxide production by hepatocytes. Inhibition of toxicity was not due to alterations in acetaminophen metabolism since aminoguanidine had no effect on hepatocyte cytochrome P4502E1 protein expression or N‐acetyl‐p‐benzoquinone‐imine formation. Taken together, these data demonstrate that nitric oxide is an important mediator of acetaminophen‐induced hepatotoxicity.

[1]  D. Heck,et al.  Arginine metabolism in keratinocytes and macrophages during nitric oxide biosynthesis: multiple modes of action of nitric oxide synthase inhibitors. , 1997, Biochemical pharmacology.

[2]  A. Cederbaum,et al.  Inhibition of rat and human cytochrome P4502E1 catalytic activity and reactive oxygen radical formation by nitric oxide. , 1997, Archives of biochemistry and biophysics.

[3]  R. Bartrons,et al.  Nitric oxide inhibits DNA synthesis and induces activation of poly(ADP-ribose) polymerase in cultured rat hepatocytes. , 1996, Experimental cell research.

[4]  J. Lancaster,et al.  Nitric Oxide Mediates Hepatic Cytochrome P450 Dysfunction Induced by Endotoxin , 1996, Anesthesiology.

[5]  T. Pineau,et al.  Role of CYP2E1 in the Hepatotoxicity of Acetaminophen (*) , 1996, The Journal of Biological Chemistry.

[6]  R. Landmann,et al.  Human monocyte CD14 is upregulated by lipopolysaccharide , 1996, Infection and immunity.

[7]  C. Thiemermann,et al.  Comparison of the effects of aminoguanidine and N omega-nitro-L-arginine methyl ester on the multiple organ dysfunction caused by endotoxaemia in the rat. , 1996, European journal of pharmacology.

[8]  P. D. Hodgson,et al.  The role of nitric oxide generation in interferon-evoked cytochrome P450 down-regulation. , 1995, International journal of immunopharmacology.

[9]  C. Thiemermann,et al.  The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthase , 1995, British journal of pharmacology.

[10]  J. Doehmer,et al.  Inhibition of biotransformation by nitric oxide (NO) overproduction and toxic consequences. , 1995, Toxicology letters.

[11]  M. Luster,et al.  Tumor necrosis factor-alpha and nitric oxide production in endotoxin-primed rats administered carbon tetrachloride. , 1995, Life sciences.

[12]  A. Nussler,et al.  Nitric oxide, hepatocytes and inflammation. , 1995, Research in immunology.

[13]  K. Decker,et al.  Cytokines, nitric oxide synthesis and liver regeneration , 1995, Journal of gastroenterology and hepatology.

[14]  D. Laskin,et al.  Hepatic nitric oxide production following acute endotoxemia in rats is mediated by increased inducible nitric oxide synthase gene expression , 1995, Hepatology.

[15]  R. Wilson,et al.  Role of proinflammatory cytokines in acetaminophen hepatotoxicity. , 1995, Toxicology and applied pharmacology.

[16]  D. Laskin,et al.  Modulation of macrophage functioning abrogates the acute hepatotoxicity of acetaminophen , 1995, Hepatology.

[17]  J. Spitzer,et al.  Chronic alcohol administration stimulates nitric oxide formation in the rat liver with or without pretreatment by lipopolysaccharide. , 1995, Alcoholism, clinical and experimental research.

[18]  D. Laskin,et al.  Distinct biochemical responses of hepatic macrophages and endothelial cells to platelet‐activating factor during endotoxemia , 1995, Journal of leukocyte biology.

[19]  D. Laskin,et al.  Distinct patterns of nitric oxide production in hepatic macrophages and endothelial cells following acute exposure of rats to endotoxin , 1994, Journal of leukocyte biology.

[20]  D. Bundschuh,et al.  Induction of hepatic ito cell nitric oxide production after acute endotoxemia , 1994, Hepatology.

[21]  R. Mason,et al.  Nitric oxide production during endotoxic shock in carbon tetrachloride-treated rats. , 1994, Molecular pharmacology.

[22]  P. Klatt,et al.  Uptake of nitric oxide synthase inhibitors by macrophage RAW 264.7 cells. , 1994, The Biochemical journal.

[23]  J. Pearson,et al.  Discrimination between citrulline and arginine transport in activated murine macrophages: inefficient synthesis of NO from recycling of citrulline to arginine , 1994, British journal of pharmacology.

[24]  G. Mann,et al.  Selective targeting of nitric oxide synthase inhibitors to system y+ in activated macrophages. , 1994, Biochemical and biophysical research communications.

[25]  J. Siewert,et al.  Inhibition of cytochromes P4501A by nitric oxide. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[26]  D. Laskin,et al.  Regulation of hepatic endothelial cell and macrophage proliferation and nitric oxide production by GM‐CSF, M‐CSF, and IL‐1β following acute endotoxemia , 1994, Journal of leukocyte biology.

[27]  J. Pearson,et al.  Selective inhibition by dexamethasone of induction of NO synthase, but not of induction of l‐arginine transport, in activated murine macrophage J774 cells , 1993, British journal of pharmacology.

[28]  J. Vane,et al.  Nitric oxide is a mediator of the decrease in cytochrome P450-dependent metabolism caused by immunostimulants. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[29]  T. Evans,et al.  Aminoguanidine selectively inhibits inducible nitric oxide synthase , 1993, British journal of pharmacology.

[30]  P. Klatt,et al.  Characterization of endothelial cell amino acid transport systems involved in the actions of nitric oxide synthase inhibitors. , 1993, Molecular pharmacology.

[31]  J. Perkins,et al.  Differential effects of antimycin A on endocytosis and exocytosis of transferrin also are observed for internalization and externalization of beta-adrenergic receptors. , 1993, Molecular pharmacology.

[32]  J. Lancaster,et al.  Induction of nitric oxide synthesis and its reactions in cultured human and rat hepatocytes stimulated with cytokines plus LPS. , 1993, Biochemical and biophysical research communications.

[33]  A. Schousboe,et al.  Transport of l‐[3H]Arginine in Cultured Neurons: Characteristics and Inhibition by Nitric Oxide Synthase Inhibitors , 1993, Journal of neurochemistry.

[34]  J S Beckman,et al.  Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. , 1992, Archives of biochemistry and biophysics.

[35]  J S Beckman,et al.  Peroxynitrite formation from macrophage-derived nitric oxide. , 1992, Archives of biochemistry and biophysics.

[36]  S. Moncada,et al.  L-arginine transport is increased in macrophages generating nitric oxide. , 1992, The Biochemical journal.

[37]  S. Moncada,et al.  Identification of inhibitors of nitric oxide synthase that do not interact with the endothelial cell l‐arginine transporter , 1992, British journal of pharmacology.

[38]  T. Ishikawa,et al.  Apoptosis in cultured rat hepatocytes: The effects of tumour necrosis factor α and interferon γ , 1991 .

[39]  T. Billiar,et al.  Nitric oxide and nitric oxide‐generating compounds inhibit hepatocyte protein synthesis , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[40]  B. Freeman,et al.  Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. , 1991, The Journal of biological chemistry.

[41]  R. L. Simmons,et al.  Modulation of Nitrogen Oxide Synthesis In Vivo: NG‐Monomethyl‐L‐Arginine Inhibits Endotoxin‐Induced Nitrate/Nitrate Biosynthesis While Promoting Hepatic Damage , 1990, Journal of leukocyte biology.

[42]  T. Billiar,et al.  Hepatocytes produce nitrogen oxides from L-arginine in response to inflammatory products of Kupffer cells , 1989, The Journal of experimental medicine.

[43]  P. Thomas,et al.  Regulation of cytochrome P-450j, a high-affinity N-nitrosodimethylamine demethylase, in rat hepatic microsomes. , 1987, Biochemistry.

[44]  D. Laskin,et al.  Potential role of activated macrophages in acetaminophen hepatotoxicity. II. Mechanism of macrophage accumulation and activation. , 1986, Toxicology and applied pharmacology.

[45]  D. Laskin,et al.  Potential role of activated macrophages in acetaminophen hepatotoxicity. I. Isolation and characterization of activated macrophages from rat liver. , 1986, Toxicology and applied pharmacology.

[46]  D. Laskin,et al.  Accumulation of Activated Mononuclear Phagocytes in the Liver Following Lipopolysaccharide Treatment of Rats , 1986, Journal of leukocyte biology.

[47]  D. Jollow,et al.  Strain differences in susceptibility of normal and diabetic rats to acetaminophen hepatotoxicity. , 1986, Biochemical pharmacology.

[48]  S. Tannenbaum,et al.  Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. , 1982, Analytical biochemistry.

[49]  M. Sole,et al.  Plasma dopamine responses to standing and exercise in man. , 1979, Life sciences.

[50]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[51]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[52]  K. Reuhl,et al.  Protective effects of garlic and related organosulfur compounds on acetaminophen-induced hepatotoxicity in mice. , 1996, Toxicology and applied pharmacology.

[53]  D. J. Wolff,et al.  Aminoguanidine is an isoform-selective, mechanism-based inactivator of nitric oxide synthase. , 1995, Archives of biochemistry and biophysics.

[54]  S. Gross,et al.  Nitric oxide: pathophysiological mechanisms. , 1995, Annual review of physiology.

[55]  D. Wink,et al.  Inhibition of cytochromes P450 by nitric oxide and a nitric oxide-releasing agent. , 1993, Archives of biochemistry and biophysics.

[56]  A. Li,et al.  Arginine transport in human liver. Characterization and effects of nitric oxide synthase inhibitors. , 1993, Annals of surgery.

[57]  P. López-Jaramillo,et al.  The L-arginine: nitric oxide pathway. , 1993, Current opinion in nephrology and hypertension.

[58]  M. Mcdaniel,et al.  Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. , 1993, European journal of pharmacology.

[59]  S. Morris,et al.  Regulation of enzymes of urea and arginine synthesis. , 1992, Annual review of nutrition.